文献速递心境障碍精神分裂症与精神病性障碍物质与行为成瘾

精神障碍家族聚集性的绝对风险与相对风险:丹麦登记研究

Absolute and relative risks of mental disorders in families: a Danish register-based study.
PubMed 文献 · Lancet Psychiatry · 2025-01-01

该前瞻性队列研究纳入1970至2021年丹麦籍个体3 048 583人,随访80 425 971人年,估算各类精神障碍的终生风险、年龄别绝对风险与相对风险及遗传度。结果显示亲属患病者同类障碍风险升高且亲缘越近风险越高;从人群看多数病例发生于无患病近亲者。

要点

  • 亲属患同类精神障碍者终生风险与相对风险均升高,亲缘越近风险越高

核心结论

  • 有家族成员患某类精神障碍的个体,患同类障碍的风险升高;从人群角度看多数精神障碍发生于无患病近亲的个体,提示预防策略应覆盖全人群。

研究设计与样本

  • 数据来自丹麦民事登记系统、多代登记系统、精神病学中央研究登记与国家患者登记,链接个体及其扩展家系的精神健康信息。
  • 考察障碍包括物质使用障碍、大麻使用障碍、酒精使用障碍、精神分裂症及相关障碍、精神分裂症、分裂情感性障碍、心境障碍、双相障碍、单次与复发性抑郁障碍(抑郁症)、人格障碍、边缘型人格障碍与反社会型人格障碍。
  • 估算终生风险(至60岁)、年龄别绝对风险、相对风险(按一级、二级、三级亲属)、遗传度及非家族性病例比例,并有相关亲身经历者参与研究设计与实施。

主要发现

  • 有家族成员患某类精神障碍者,患同类障碍的终生风险与相对风险均更高。
  • 终生风险与相对风险均随患病亲属亲缘关系越近而升高。

临床怎么用

  • 对有一级、二级亲属患特定精神障碍的就诊者,可按相应终生风险水平提高监测与早期识别强度。
  • 鉴于非家族性病例占多数,预防与筛查策略不宜仅针对有家族史者,应兼顾全人群。

局限性

  • 原文摘要未报告除丹麦人群外其他人群的推广性证据,亦未提供各类障碍风险估计的完整数值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Relative risk estimates of familial aggregation of many types of mental disorders are available, but absolute risk estimates of familial aggregation of mental disorders remain sparse. The proportion of individuals who develop a mental disorder in the absence of the same disorder in a relative (non-familial cases) has not been examined. We aimed to create comprehensive risk estimates of the familial aggregation of mental disorders. METHODS: In this prospective cohort study, we followed people of Danish origin between Jan 1, 1970, and Dec 31, 2021. We used Danish population-based registers to link individuals and their mental health across extended family pedigrees. These registers include the Danish Civil Registration System, the Danish Multi Generation Register, the Danish Psychiatric Central Research Register, and the Danish National Patient Register. Mental disorders investigated were substance use disorder, cannabis use disorder, alcohol use disorder, schizophrenia and related disorders, schizophrenia, schizoaffective disorder, mood disorders, bipolar disorder, single and recurrent depressive disorders (depression), personality disorder, borderline personality disorder, and antisocial personality disorder. We estimated lifetime risk (risk up to age 60 years), age-specific absolute risk, and relative risk for each mental disorder and type of affected relative (eg first, second, or third-degree relatives). We calculated heritability estimates and the proportion of non-familial cases. We involved people with related lived experience in the study design and implementation. FINDINGS: A total of 3 048 583 individuals (1 486 132 [48·75%] females and 1 562 451 [51·25%] males) were followed up for 80 425 971 person-years. Individuals with a family member with a specific type of mental disorder had higher lifetime and relative risks of developing the same type of mental disorder. Both lifetime and relative risks were higher the closer the affected kinship. For example, the lifetime risk of depression was 15·48% (95% CI 15·31-15·65) in individuals with affected first-degree relatives, 13·50% (13·25-13·75) in individuals with affected second-degree relatives, 7·80% (7·76-7·84) in the general population, and 4·68% (4·65-4·71) in individuals without affected first-degree and second-degree relatives. The heritability for depression was 45·4% (95% CI 44·8-46·0) and the proportion of non-familial cases constituted 60·0% (95% CI 59·8-60·2). INTERPRETATION: Individuals with family members with a mental disorder face increased risks of the same disorder. From a population perspective, most mental disorders occur in individuals without affected close relatives, thus highlighting the need for prevention strategies which target the entire population. FUNDING: Novo Nordisk Foundation. TRANSLATION: For the Danish translation of the abstract see Supplementary Materials section.

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. Pedersen CB, Pedersen MG, Antonsen S, et al. Absolute and relative risks of mental disorders in families: a Danish register-based study. Lancet Psychiatry. 2025. PMID: 40675715. doi:10.1016/S2215-0366(25)00196-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。